The low mortality rates observed with directional atherectomy or stenting in stable angina patients with EF >30% suggest that a randomized trial comparing these interventions to bypass surgery is warranted.
Answers are grounded in this paper and cite their sources.
Low mortality in this case series warrants no practice change; leaves open whether atherectomy or stenting rivals bypass in stable angina.
in-hospital cardiac mortality rate for patients with ejection fraction Ͼ30% who present with stable angina and who are treated with directional atherectomy or stenting is only 1.3% in this series and their 9-month mortality rate is 4.4%, it may be that now is an appropriate time for a randomized, controlled trial in such patients against the current gold standard: bypass surgery.
No takes yet. Share an insight, caveat, or question.
Kuo et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: